Literature DB >> 12568291

A hospital-based study on the use of alternative medicine in patients with chronic liver and gastrointestinal diseases.

Zinger C Yang1, Sien-Hung Yang, Sien-Sing Yang, Ding-Shinn Chen.   

Abstract

To determine the extent to which Taiwanese patients use alternative medicine, we interviewed 500 consecutive patients with chronic liver and gastrointestinal disorders at an outpatient-service. Forty-two patients were excluded due to incomplete data. The percentages of patients with chronic liver (102/269, 37.9%) and gastrointestinal (74/189, 39.2%) diseases using alternative medicine were not significantly different (p = 0.70). The patients who used alternative medicine were not statistically different in gender (p = 0.37), age (p = 0.59), education level (p = 0.83), family income (p = 0.90), or occupation (p = 0.72). Only 36% (64/176) of patients informed their doctors of their use of alternative medicine. The kinds of alternative medicine used by the 176 patients included: Chinese/herbal medicine, 169 (96%); acupuncture, 31 (18%); nutritional supplements, 22 (13%); chiropractic, 17 (10%); scratching, 14 (8%); Qigong, 13 (7%); cupping, 13 (7%); and incense ash, 3 (2%). Sixty-six percent (111/169) of patients used Chinese/herbal medicine in addition to Western allopathic medicine. Only 11% (19/169) of them believed that Chinese/herbal medicine had side effects. Our study indicates the use of alternative medicine occurs across all demographic groups in one-third of patients with chronic liver and gastrointestinal diseases at a major general hospital in Taipei. We suggest that the doctors question all patients for history of alternative therapy use.

Entities:  

Mesh:

Year:  2002        PMID: 12568291     DOI: 10.1142/S0192415X02000569

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  9 in total

1.  Complementary and alternative medicine use in chronic liver disease patients.

Authors:  Leah M Ferrucci; Beth P Bell; Kathy B Dhotre; M Michele Manos; Norah A Terrault; Atif Zaman; Rosemary C Murphy; Grace R Vanness; Ann R Thomas; Stephanie R Bialek; Mayur M Desai; Andre N Sofair
Journal:  J Clin Gastroenterol       Date:  2010-02       Impact factor: 3.062

2.  Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

Authors:  Colin P White; Gerilynn Hirsch; Sunil Patel; Fatin Adams; Kevork M Peltekian
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

3.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

4.  The usage of complementary and alternative medicine in gastrointestinal patients visiting the outpatients' department of a large tertiary care centre-views from Pakistan.

Authors:  Ghulamullah Lail; Nasir Luck; Abbas Ali Tasneem; AyeshaAslam Rai; Syed Mudasir Laeeq; Zain Majid
Journal:  Pan Afr Med J       Date:  2016-07-15

Review 5.  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.

Authors:  Peter J H Beliveau; Jessica J Wong; Deborah A Sutton; Nir Ben Simon; André E Bussières; Silvano A Mior; Simon D French
Journal:  Chiropr Man Therap       Date:  2017-11-22

6.  Electroacupuncture for Functional Constipation: A Multicenter, Randomized, Control Trial.

Authors:  Xiao Wu; Cuihong Zheng; Xiaohu Xu; Pei Ding; Fan Xiong; Man Tian; Ying Wang; Haoxu Dong; Mingmin Zhang; Wei Wang; Shabei Xu; Minjie Xie; Guangying Huang
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-31       Impact factor: 2.629

7.  Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.

Authors:  Chin-Tsung Ting; Chian-Jue Kuo; Hsiao-Yun Hu; Ya-Ling Lee; Tung-Hu Tsai
Journal:  BMC Complement Altern Med       Date:  2017-02-20       Impact factor: 3.659

8.  Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats.

Authors:  Chin-Tsung Ting; Yung-Yi Cheng; Tung-Hu Tsai
Journal:  Molecules       Date:  2017-06-22       Impact factor: 4.411

9.  Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.

Authors:  Kayla Gelow; Sai Chalasani; Kelsey Green; Craig Lammert
Journal:  Dig Dis Sci       Date:  2021-06-23       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.